Tillis 101 bill not perfect but still ‘major milestone’: in-house
Counsel at IBM, Novartis, BMS and four other companies delve into whether the new Section 101 bill addresses their concerns
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: